Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Disability
News Release
Genex Social Security Division Receives Supplier of the Year Award from Unum
WAYNE, Pa.
Workers' Comp
White Paper
Transforming Big Data into Applied Analytics
Over the past few years, Big Data has captured the interest of the nation’s top business leaders.
Workers' Comp
News Release
Genex Services Outlines Top Barriers to Effective Return-to-Work Programs
Notes strong RTW programs reduce disability duration for costly long term disability case
Business Insurance
In the News
Traffic accidents are a leading cause of serious workers comp injuries
Workers' Comp
News Release
WorkCompCentral: Payers, Regulators Push for Limits on 2 Chronic Pain Treatments
Read here with subscription.
Workers' Comp
News Release
Genex Announces Case Manager Scholarship Award Recipients
WAYNE, Pa.